Perspective Therapeutics, Inc. - CATX

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
Mar 10, 2026 SCHEDULE 13G Avidity Partners Management LP 5.3% 6,049,999 View
Mar 10, 2026 SCHEDULE 13G Avidity Partners Management (GP) LLC 5.3% 6,049,999 View
Mar 10, 2026 SCHEDULE 13G Avidity Capital Partners Fund (GP) LP 5.3% 6,049,999 View
Mar 10, 2026 SCHEDULE 13G Avidity Capital Partners (GP) LLC 5.3% 6,049,999 View
Mar 10, 2026 SCHEDULE 13G Avidity Private Master Fund I LP 5.1% 5,849,999 View
Mar 10, 2026 SCHEDULE 13G Michael Gregory 5.3% 6,049,999 View
Feb 12, 2026 SCHEDULE 13G Morgan Stanley 6.0% 4,461,893 View
Feb 09, 2026 SCHEDULE 13G Commodore Capital LP 9.9% 11,939,753 View
Feb 09, 2026 SCHEDULE 13G Commodore Capital Master LP 9.9% 11,939,753 View
Feb 09, 2026 SCHEDULE 13G Robert Egen Atkinson 9.9% 11,939,753 View
Feb 09, 2026 SCHEDULE 13G Michael Kramarz 9.9% 11,939,753 View
Feb 06, 2026 SCHEDULE 13G TCG Crossover GP II, LLC 3.5% 3,957,784 View
Feb 06, 2026 SCHEDULE 13G TCG Crossover Fund II, L.P. 3.5% 3,957,784 View
Feb 06, 2026 SCHEDULE 13G TCG Crossover GP III, LLC 3.5% 3,957,783 View
Feb 06, 2026 SCHEDULE 13G TCG Crossover Fund III, L.P. 3.5% 3,957,783 View
Feb 06, 2026 SCHEDULE 13G Chen Yu 6.9% 7,915,567 View
Feb 05, 2026 SCHEDULE 13G Qatar Investment Authority 6.2% 7,073,308 View
Dec 05, 2025 SCHEDULE 13G/A FMR LLC 0.4% 312,164 View
Dec 05, 2025 SCHEDULE 13G/A Abigail P. Johnson 0.4% 312,164 View
Nov 07, 2025 SCHEDULE 13G/A FMR LLC 8.2% 6,063,330 View
Nov 07, 2025 SCHEDULE 13G/A Abigail P. Johnson 8.2% 6,063,330 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.